AI Enhances Drug Discovery and Development

Fang Bai,Shiliang Li,Honglin Li

DOI: https://doi.org/10.1093/nsr/nwad303

IF: 20.6

2024-01-01

National Science Review

Abstract:>The advent of the third wave of artificial intelligence(AI) heralds a new era in drug discovery. AI-powered techniques can be characteristic of identifying features that are difficult for humans to interpret from big and high-dimensional data in biomedical research.

What problem does this paper attempt to address?

Artificial intelligence facilitates drug design in the big data era

Liangliang Wang,Junjie Ding,Li Pan,Dongsheng Cao,Hui Jiang,Xiaoqin Ding

DOI: https://doi.org/10.1016/j.chemolab.2019.103850

IF: 4.175

2019-11-01

Chemometrics and Intelligent Laboratory Systems

Abstract:With the dramatic development of high-performance computing, the emergence of better algorithms and the accumulation of large amounts of chemical and biological data, computer-aided drug design technology is playing an increasingly prominent role in drug discovery and development with its advantages of fast speed, low cost and high efficiency. In recent years, due to the constant development of machine learning (ML) theory, artificial intelligence (AI), a powerful data mining technology has been widely used in various stages of drug design. More recently, drug design has entered the era of big data, ML methods have gradually evolved into a deep learning (DL) method with stronger generalization ability and more effective big data processing, which further promotes the combination of AI technology and computer-aided drug design technology, thus facilitating the discovery and design of new drugs. This paper mainly summarizes the application progress of AI technology in drug design process, analyses and compares its advantages over traditional methods. Finally, the challenges faced by AI technology and its application prospects in the field of drug design are also discussed.

automation & control systems,computer science, artificial intelligence,instruments & instrumentation,statistics & probability,mathematics, interdisciplinary applications,chemistry, analytical
Artificial Intelligence in Pharmaceutical Sciences

Mingkun Lu,Jiayi Yin,Qi Zhu,Gaole Lin,Minjie Mou,Fuyao Liu,Ziqi Pan,Nanxin You,Xichen Lian,Fengcheng Li,Hongning Zhang,Lingyan Zheng,Wei Zhang,Hanyu Zhang,Zihao Shen,Zhen Gu,Honglin Li,Feng Zhu

DOI: https://doi.org/10.1016/j.eng.2023.01.014

IF: 12.834

2023-04-01

Engineering

Abstract:Drug discovery and development affects various aspects of human health and dramatically impacts the pharmaceutical market. However, investments in a new drug often go unrewarded due to the long and complex process of drug research and development (R&D). With the advancement of experimental technology and computer hardware, artificial intelligence (AI) has recently emerged as a leading tool in analyzing abundant and high-dimensional data. Explosive growth in the size of biomedical data provides advantages in applying AI in all stages of drug R&D. Driven by big data in biomedicine, AI has led to a revolution in drug R&D, due to its ability to discover new drugs more efficiently and at lower cost. This review begins with a brief overview of common AI models in the field of drug discovery; then, it summarizes and discusses in depth their specific applications in various stages of drug R&D, such as target discovery, drug discovery and design, preclinical research, automated drug synthesis, and influences in the pharmaceutical market. Finally, the major limitations of AI in drug R&D are fully discussed and possible solutions are proposed.

engineering, multidisciplinary
Artificial Intelligence for Drug Discovery: Resources, Methods, and Applications

Wei Chen,Xuesong Liu,Sanyin Zhang,Shilin Chen

DOI: https://doi.org/10.1016/j.omtn.2023.02.019

2023-02-19

Abstract:Conventional wet laboratory testing, validations, and synthetic procedures are costly and time-consuming for drug discovery. Advancements in artificial intelligence (AI) techniques have revolutionized their applications to drug discovery. Combined with accessible data resources, AI techniques are changing the landscape of drug discovery. In the past decades, a series of AI-based models have been developed for various steps of drug discovery. These models have been used as complements of conventional experiments and have accelerated the drug discovery process. In this review, we first introduced the widely used data resources in drug discovery, such as ChEMBL and DrugBank, followed by the molecular representation schemes which convert data into computer-readable formats. Meanwhile, we summarized the algorithms used to develop AI-based models for drug discovery. Subsequently, we discussed the applications of AI techniques in pharmaceutical analysis including predicting drug toxicity, drug bioactivity, and drug physicochemical property. Furthermore, we introduced the AI-based models for de novo drug design, drug target structure prediction, drug-target interaction and binding affinity prediction. Moreover, we also highlighted the advanced applications of AI in drug synergism/antagonism prediction and nanomedicine design. Finally, we discussed the challenges and future perspectives on the applications of AI to drug discovery.

medicine, research & experimental
The Role of AI in Drug Discovery

Mohamed Abbas,Abrar Rassam,Rehab Abunora,Fatima Karamshahi,Maha Abouseada

DOI: https://doi.org/10.1002/cbic.202300816

IF: 3.2

2024-05-13

ChemBioChem

Abstract:The emergence of Artificial Intelligence (AI) in drug discovery marks a pivotal shift in pharmaceutical research, blending sophisticated computational techniques with conventional scientific exploration to break through enduring obstacles. This review paper elucidates the multifaceted applications of AI across various stages of drug development, highlighting significant advancements and methodologies. It delves into AI's instrumental role in drug design, polypharmacology, chemical synthesis, drug repurposing, and the prediction of drug properties such as toxicity, bioactivity, and physicochemical characteristics. Despite AI's promising advancements, the paper also addresses the challenges and limitations encountered in the field, including data quality, generalizability, computational demands, and ethical considerations. By offering a comprehensive overview of AI's role in drug discovery, this paper underscores the technology's potential to significantly enhance drug development, while also acknowledging the hurdles that must be overcome to fully realize its benefits.

biochemistry & molecular biology,chemistry, medicinal
The Role of Artificial Intelligence in Drug Discovery and Development

Michael Liebman

DOI: https://doi.org/10.1515/ci-2022-0105

2022-01-01

Chemistry International

Abstract:Abstract Artificial Intelligence (AI) is an exciting, growing field. Due to the high and growing number of data, the comprehensive evaluation of information behind data makes AI tools indispensable. In Drug Discovery and Development the application of AI has become important to accelerate progress and enhance decision making in many fields and disciplines of medicinal chemistry, upscaling, molecular and cell biology, pharmacology, pharmacokinetics, formulation development and toxicology. In clinical testing AI has high importance in increasing success rates by enhancing trial design (biomarkers, efficacy parameters, dose selection, trial duration), selection of the target patient population, patient stratification and evaluation of patient samples. The increasing relevance of AI in drug discovery and development is reflected by the growing number of start-up companies specialized in this field, the growing number of collaborations from Pharma with AI platforms, and the high number of articles and reviews reporting current applications, their success and limitations.
Accelerating drug discovery, development, and clinical trials by artificial intelligence

Yilun Zhang,Mohamed Mastouri,Yang Zhang

DOI: https://doi.org/10.1016/j.medj.2024.07.026

2024-08-10

Med

Abstract:Artificial intelligence (AI) has profoundly advanced the field of biomedical research, which also demonstrates transformative capacity for innovation in drug development. This paper aims to deliver a comprehensive analysis of the progress in AI-assisted drug development, particularly focusing on small molecules, RNA, and antibodies. Moreover, this paper elucidates the current integration of AI methodologies within the industrial drug development framework. This encompasses a detailed examination of the industry-standard drug development process, supplemented by a review of medications presently undergoing clinical trials. Conclusively, the paper tackles a predominant obstacle within the AI pharmaceutical sector: the absence of AI-conceived drugs receiving approval. This paper also advocates for the adoption of large language models and diffusion models as a viable strategy to surmount this challenge. This review not only underscores the significant potential of AI in drug discovery but also deliberates on the challenges and prospects within this dynamically progressing field.
Artificial Intelligence Assisted Drug Research and Development

Kanishka Soni,Yasha Hasija

DOI: https://doi.org/10.1109/delcon54057.2022.9753179

2022-02-11

Abstract:Artificial Intelligence, abbreviated as AI, is described as a collection of technologies that work together to allow machines to discern, interpret, take action, and acquire knowledge with human level of intelligence. The AI domain includes technologies such as natural language processing (NLP) and machine learning (ML). Each of these is on its separate route of development and, when combined with datasets, analytics, and computerization, may assist organisations in achieving their objectives, whether it's enhancing customer service or improving supply chain. The pipeline of the development of novel drugs is quite extensive and costly apart from being complicated. On average, this entire process requires around 12 years costing approximately 2.6 billion USD. In this age of computational power, AI-based techniques are used in almost all of the steps during the process of discovering and developing drugs. AI has been able to reduce the time requirement and amount of money involved in this process thus expediting the entire procedure of new pharmaceutical inventions. In this manuscript, we have discussed some of the major applications of AI in the pharmaceutical sector. Tools that are employed to forecast the toxicity of drugs and how some of them, for example - Toxtree, ADMET, ProTox etc. have been used by researchers in the drug discovery process, have also been talked about. Further we have mentioned how AI is proving to be a powerful tool in the fight against the COVID-19 pandemic, for example, in the detection of the SARS-Co V -2 virus, development of vaccines, genomics etc. In addition to this, we have discussed about the manner in which the penetration of AI-based companies into the pharmaceutical field has resulted in some notable outcomes, for instance - prediction of the 3-dimensional structure of proteins by DeepMind's AlphaFold2, determination of new drug contender for kidney fibrosis by Insilico Medicine's Chemistry42 etc. Furthermore, we have stated the propitious future that AI is expected to bring about in the pharma world with a special focus on drug development.
Advances in Drug Design and Development for Human Therapeutics Using Artificial Intelligence—I

Dongqing Wei,Gurudeeban Selvaraj,Yanjing Wang,Gilles H. Peslherbe

DOI: https://doi.org/10.3390/biom12121846

IF: 6.064

2022-12-11

Biomolecules

Abstract:Artificial intelligence (AI) has emerged as a key player in modern healthcare, especially in the pharmaceutical industry for the development of new drugs and vaccine candidates [...]

biochemistry & molecular biology
From understanding diseases to drug design: can artificial intelligence bridge the gap?

Anju Choorakottayil Pushkaran,Alya A. Arabi

DOI: https://doi.org/10.1007/s10462-024-10714-5

IF: 9.588

2024-03-12

Artificial Intelligence Review

Abstract:Artificial intelligence (AI) has emerged as a transformative technology with significant potential to revolutionize disease understanding and drug design in healthcare. AI serves as a remarkable accelerating tool that bridges the gap between understanding diseases and discovering drugs. Given its capacity in the analysis and interpretation of massive amounts of data, AI is tremendously boosting the power of predictions with impressive accuracies. This allowed AI to pave the way for advancing all key stages of drug development, with the advantage of expediting the drug discovery process and curbing its costs. This is a comprehensive review of the recent advances in AI and its applications in drug discovery and development, starting with disease identification and spanning through the various stages involved in the drug discovery pipeline, including target identification, screening, lead discovery, and clinical trials. In addition, this review discusses the challenges that arise during the implementation of AI at each stage of the discovery process and provides insights into the future prospects of this field.

computer science, artificial intelligence
New avenues in artificial-intelligence-assisted drug discovery

Carmen Cerchia,Antonio Lavecchia

DOI: https://doi.org/10.1016/j.drudis.2023.103516

IF: 8.369

2023-02-05

Drug Discovery Today

Abstract:Over the past decade, the amount of biomedical data available has grown at unprecedented rates. Increased automation technology and larger data volumes have encouraged the use of machine learning (ML) or artificial intelligence (AI) techniques for mining such data and extracting useful patterns. Because the identification of chemical entities with desired biological activity is a crucial task in drug discovery, AI technologies have the potential to accelerate this process and support decision...

pharmacology & pharmacy
The potential applications of artificial intelligence in drug discovery and development

H Farghali,N Kutinová Canová,M Arora

DOI: https://doi.org/10.33549/physiolres.934765

2021-12-30

Abstract:Development of a new dug is a very lengthy and highly expensive process since only preclinical, pharmacokinetic, pharmacodynamic and toxicological studies include a multiple of in silico, in vitro, in vivo experimentations that traditionally last several years. In the present review, we briefly report some examples that demonstrate the power of the computer-assisted drug discovery process with some examples that are published and revealing the successful applications of artificial intelligence (AI) technology on this vivid area. Besides, we address the situation of drug repositioning (repurposing) in clinical applications. Yet few success stories in this regard that provide us with a clear evidence that AI will reveal its great potential in accelerating effective new drug finding. AI accelerates drug repurposing and AI approaches are altogether necessary and inevitable tools in new medicine development. In spite of the fact that AI in drug development is still in its infancy, the advancements in AI and machine-learning (ML) algorithms have an unprecedented potential. The AI/ML solutions driven by pharmaceutical scientists, computer scientists, statisticians, physicians and others are increasingly working together in the processes of drug development and are adopting AI-based technologies for the rapid discovery of medicines. AI approaches, coupled with big data, are expected to substantially improve the effectiveness of drug repurposing and finding new drugs for various complex human diseases.
Piquing artificial intelligence towards drug discovery: Tools, techniques, and applications

Peter Chinedu Agu,Chidiebere Nwiboko Obulose

DOI: https://doi.org/10.1002/ddr.22159

2024-02-21

Drug Development Research

Abstract:The purpose of this study was to discuss how artificial intelligence (AI) methods have affected the field of drug development. It looks at how AI models and data resources are reshaping the drug development process by offering more affordable and expedient options to conventional approaches. The paper opens with an overview of well‐known information sources for drug development. The discussion then moves on to molecular representation techniques that make it possible to convert data into representations that computers can understand. The paper also gives a general overview of the algorithms used in the creation of drug discovery models based on AI. In particular, the paper looks at how AI algorithms might be used to forecast drug toxicity, drug bioactivity, and drug physicochemical properties. De novo drug design, binding affinity prediction, and other AI‐based models for drug–target interaction were covered in deeper detail. Modern applications of AI in nanomedicine design and pharmacological synergism/antagonism prediction were also covered. The potential advantages of AI in drug development are highlighted as the evaluation comes to a close. It underlines how AI may greatly speed up and improve the efficiency of drug discovery, resulting in the creation of new and better medicines. To fully realize the promise of AI in drug discovery, the review acknowledges the difficulties that come with its uses in this field and advocates for more study and development.

pharmacology & pharmacy,chemistry, medicinal
Employing Artificial Intelligence Methods in Drug Development: A New Era in Medicine

Omega John Unogwu,Mabel Ike,Opkanachi Omatule Joktan

DOI: https://doi.org/10.58496/mjaih/2023/010

2023-10-20

Abstract:Artificial intelligence (AI) plays a vital role in the development of pharmaceuticals. The whole drug development process, from target identification and lead optimization to clinical trials and post-marketing monitoring, has the potential to be revolutionized by AI. Data analysis is a crucial area where AI thrives. To find trends, correlations, and prospective targets for therapeutic intervention, AI systems can analyse enormous volumes of data, including electronic health records, molecular databases, academic literature, and clinical trial data. This saves time and resources by enabling researchers to decide which compounds or pathways to investigate. Lead optimization is another area where AI is essential since algorithms can screen and forecast the efficacy of new drug candidates. To improve efficacy, safety, and pharmacokinetics, the most promising leads are prioritized, and their attributes are optimized. By examining past data to pinpoint patient groupings that are most likely to respond to a certain medication, AI can also improve clinical trial design and patient selection. This advances success rates aids in the development of personalized medication and can support post-marketing surveillance by continuously scanning real-world data for adverse events or unexpected drug-drug interactions after a medicine has been licensed. This permits the quicker detection of potential safety issues and contributes to maintaining the continuous safety of licensed medications. However, some obstacles must be overcome to completely utilize AI in medication development. These include the requirement for high-quality data, assuring AI model transparency and interpretability, taking into account ethical issues, and regulatory frameworks for using AI in drug development.

Medicine,Computer Science
The changing scenario of drug discovery using AI to deep learning: Recent advancement, success stories, collaborations, and challenges

Chiranjib Chakraborty,Manojit Bhattacharya,Sang-Soo Lee,Zhi-Hong Wen,Yi-Hao Lo

DOI: https://doi.org/10.1016/j.omtn.2024.102295

2024-08-08

Abstract:Due to the transformation of artificial intelligence (AI) tools and technologies, AI-driven drug discovery has come to the forefront. It reduces the time and expenditure. Due to these advantages, pharmaceutical industries are concentrating on AI-driven drug discovery. Several drug molecules have been discovered using AI-based techniques and tools, and several newly AI-discovered drug molecules have already entered clinical trials. In this review, we first present the data and their resources in the pharmaceutical sector for AI-driven drug discovery and illustrated some significant algorithms or techniques used for AI and ML which are used in this field. We gave an overview of the deep neural network (NN) models and compared them with artificial NNs. Then, we illustrate the recent advancement of the landscape of drug discovery using AI to deep learning, such as the identification of drug targets, prediction of their structure, estimation of drug-target interaction, estimation of drug-target binding affinity, design of de novo drug, prediction of drug toxicity, estimation of absorption, distribution, metabolism, excretion, toxicity; and estimation of drug-drug interaction. Moreover, we highlighted the success stories of AI-driven drug discovery and discussed several collaboration and the challenges in this area. The discussions in the article will enrich the pharmaceutical industry.
Trends of Artificial Intelligence (AI) Use in Drug Targets, Discovery and Development: Current Status and Future Perspectives

Manmayee Mohapatra,Chittaranjan Sahu,Snehamayee Mohapatra

DOI: https://doi.org/10.2174/0113894501322734241008163304

2024-10-29

Abstract:The applications of artificial intelligence (AI) in pharmaceutical sectors have advanced drug discovery and development methods. AI has been applied in virtual drug design, molecule synthesis, advanced research, various screening methods, and decision-making processes. In the fourth industrial revolution, when medical discoveries are happening swiftly, AI technology is essential to reduce the costs, effort, and time in the pharmaceutical industry. Further, it will aid "genome-based medicine" and "drug discovery." AI may prepare proactive databases according to diseases, disorders, and appropriate usage of drugs which will facilitate the required data for the process of drug development. The application of AI has improved clinical trials on patient selection in a population, stratification, and sample assessment such as biomarkers, effectiveness measures, dosage selection, and trial length. Various studies suggest AI could be perform better compared to conventional techniques in drug discovery. The present review focused on the positive impact of AI in drug discovery and development processes in the pharmaceutical industry and beneficial usage in health sectors as well.
The recent advances in the approach of artificial intelligence (AI) towards drug discovery

Mahroza Kanwal Khan,Mohsin Raza,Muhammad Shahbaz,Iftikhar Hussain,Muhammad Farooq Khan,Zhongjian Xie,Syed Shoaib Ahmad Shah,Ayesha Khan Tareen,Zoobia Bashir,Karim Khan

DOI: https://doi.org/10.3389/fchem.2024.1408740

IF: 5.5

2024-05-31

Frontiers in Chemistry

Abstract:Artificial intelligence (AI) has recently emerged as a unique developmental influence that is playing an important role in the development of medicine. The AI medium is showing the potential in unprecedented advancements in truth and efficiency. The intersection of AI has the potential to revolutionize drug discovery. However, AI also has limitations and experts should be aware of these data access and ethical issues. The use of AI techniques for drug discovery applications has increased considerably over the past few years, including combinatorial QSAR and QSPR, virtual screening, and denovo drug design. The purpose of this survey is to give a general overview of drug discovery based on artificial intelligence, and associated applications. We also highlighted the gaps present in the traditional method for drug designing. In addition, potential strategies and approaches to overcome current challenges are discussed to address the constraints of AI within this field. We hope that this survey plays a comprehensive role in understanding the potential of AI in drug discovery.

chemistry, multidisciplinary
Artificial intelligence revolutionizing drug development: Exploring opportunities and challenges

Prafulla C. Tiwari,Rishi Pal,Manju J. Chaudhary,Rajendra Nath

DOI: https://doi.org/10.1002/ddr.22115

2023-09-17

Drug Development Research

Abstract:By harnessing artificial intelligence (AI) algorithms and machine learning techniques, the entire drug discovery process stands to undergo a profound transformation, offering a myriad of advantages. Foremost among these is the ability of AI to conduct swift and efficient screenings of expansive compound libraries, significantly augmenting the identification of potential drug candidates. Moreover, AI algorithms can prove instrumental in predicting the efficacy and safety profiles of candidate compounds, thus endowing invaluable insights and reducing reliance on extensive preclinical and clinical testing. This predictive capacity of AI has the potential to streamline the drug development pipeline and enhance the success rate of clinical trials, ultimately resulting in the emergence of more efficacious and safer therapeutic agents. However, the deployment of AI in drug discovery introduces certain challenges that warrant attention. A primary hurdle entails the imperative acquisition of high‐quality and diverse data. Furthermore, ensuring the interpretability of AI models assumes critical importance in securing regulatory endorsement and cultivating trust within scientific and medical communities. Addressing ethical considerations, including data privacy and mitigating bias, represents an additional momentous challenge, requiring assiduous navigation. In this review, we provide an intricate and comprehensive overview of the multifaceted challenges intrinsic to conventional drug development paradigms, while simultaneously interrogating the efficacy of AI in effectively surmounting these formidable obstacles.

pharmacology & pharmacy,chemistry, medicinal
Artificial intelligence in drug discovery: recent advances and future perspectives

José Jiménez-Luna,Francesca Grisoni,Nils Weskamp,Gisbert Schneider

DOI: https://doi.org/10.1080/17460441.2021.1909567

2021-04-02

Expert Opinion on Drug Discovery

Abstract:Introduction: Artificial intelligence (AI) has inspired computer-aided drug discovery. The widespread adoption of machine learning, in particular deep learning, in multiple scientific disciplines, and the advances in computing hardware and software, among other factors, continue to fuel this development. Much of the initial skepticism regarding applications of AI in pharmaceutical discovery has started to vanish, consequently benefitting medicinal chemistry.Areas covered: The current status of AI in chemoinformatics is reviewed. The topics discussed herein include quantitative structure-activity/property relationship and structure-based modeling, de novo molecular design, and chemical synthesis prediction. Advantages and limitations of current deep learning applications are highlighted, together with a perspective on next-generation AI for drug discovery.Expert opinion: Deep learning-based approaches have only begun to address some fundamental problems in drug discovery. Certain methodological advances, such as message-passing models, spatial-symmetry-preserving networks, hybrid de novo design, and other innovative machine learning paradigms, will likely become commonplace and help address some of the most challenging questions. Open data sharing and model development will play a central role in the advancement of drug discovery with AI.

pharmacology & pharmacy
AI approaches for the discovery and validation of drug targets

Aaron Wenteler,Claudia P Cabrera,Wei Wei,Victor Neduva,Michael R Barnes

DOI: https://doi.org/10.1017/pcm.2024.4

2024-05-24

Abstract:Artificial intelligence (AI) holds immense promise for accelerating and improving all aspects of drug discovery, not least target discovery and validation. By integrating a diverse range of biological data modalities, AI enables the accurate prediction of drug target properties, ultimately illuminating biological mechanisms of disease and guiding drug discovery strategies. Despite the indisputable potential of AI in drug target discovery, there are many challenges and obstacles yet to be overcome, including dealing with data biases, model interpretability and generalisability, and the validation of predicted drug targets, to name a few. By exploring recent advancements in AI, this review showcases current applications of AI for drug target discovery and offers perspectives on the future of AI for the discovery and validation of drug targets, paving the way for the generation of novel and safer pharmaceuticals.
Application of Artificial Intelligence and Machine Learning in Drug Discovery and Development

Madhukiran Parvathaneni,Abduselam K. Awol,Monika Kumari,Ke Lan,Manisha Lingam

DOI: https://doi.org/10.22270/jddt.v13i1.5867

2023-01-15

Journal of Drug Delivery and Therapeutics

Abstract:Drug discovery has traditionally been a time consuming and expensive endeavor. Additionally, drugs weren’t as effectively designed as those that are being predicted and developed through AI and ML today. Machine learning is a form of artificial intelligence that develops and evolves based on experience (similarly to the human mind), and is more recently being utilized in drug discovery and design. The integration of AI and ML into the drug discovery and development process has allowed for higher target precision, lower toxicity, and better dosage formulations. AI more generally has been introduced to and has been leveraged at, each step of drug development, including target identification and validation, hit identification, as well as hit to lead optimization, and has been key in shortening the previously lengthy drug screening process. AI and ML has also been applied downstream in drug formulation where it has maximized resource utilization and is allowing for web-based 3D printing of drugs. Application of AI in the drug development process has also been extended to the modeling of novel drug-like compounds to predict their ADMET properties. This review will address the stages of drug discovery and development in which the application of AI and ML modeling has altered the traditional development of drugs. Keywords: Drug discovery, machine learning, artificial intelligence, computational drug development.

AI Enhances Drug Discovery and Development

Artificial intelligence facilitates drug design in the big data era

Artificial Intelligence in Pharmaceutical Sciences

Artificial Intelligence for Drug Discovery: Resources, Methods, and Applications

The Role of AI in Drug Discovery

The Role of Artificial Intelligence in Drug Discovery and Development

Accelerating drug discovery, development, and clinical trials by artificial intelligence

Artificial Intelligence Assisted Drug Research and Development

Advances in Drug Design and Development for Human Therapeutics Using Artificial Intelligence—I

From understanding diseases to drug design: can artificial intelligence bridge the gap?

New avenues in artificial-intelligence-assisted drug discovery

The potential applications of artificial intelligence in drug discovery and development

Piquing artificial intelligence towards drug discovery: Tools, techniques, and applications

Employing Artificial Intelligence Methods in Drug Development: A New Era in Medicine

The changing scenario of drug discovery using AI to deep learning: Recent advancement, success stories, collaborations, and challenges

Trends of Artificial Intelligence (AI) Use in Drug Targets, Discovery and Development: Current Status and Future Perspectives

The recent advances in the approach of artificial intelligence (AI) towards drug discovery

Artificial intelligence revolutionizing drug development: Exploring opportunities and challenges

Artificial intelligence in drug discovery: recent advances and future perspectives

AI approaches for the discovery and validation of drug targets

Application of Artificial Intelligence and Machine Learning in Drug Discovery and Development